Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Piper Jaffray Upgrades Power Integrations (POWI) to Neutral; Stronger Customer Demands
-
Piper Jaffray Maintains an 'Outperform' on Cogo Group (COGO); Raises PT & Estimates
-
Daily State of the Markets 02/04: Another Reality: It'll Be Slow Going
-
Piper Jaffray Upgrades Global Payments (GPN) to Overweight; Recent Pullback Creates Buying Opportunity
-
Piper Jaffray Downgrades DreamWorks Animation SKG (DWA) to Neutral; Dragon Tamed By Titans?
-
NetLogic (NETL) Gets Another Upgrade Following Earnings, This Time from DA Davidson
-
Notable Analyst Rating Changes 02/03: NETL, WMT, HHS, LXK, DKS Upgraded; CHRW, QSFT, MPWR, LOW Downgraded
-
Morning Movers 2/3: HDIX, BGP, APKT, TDSC, CGX, NETL Higher; XIDE, VSR, PLNR, R, CNLG Lower
-
Piper Jaffray Upgrades Animal Health Int'l (AHII) to Overweight; Slow Recovery, But Improving Risk Profile Warrants An Upgrade
-
Piper Jaffray Upgrades Universal Technical Institute (UTI) to Neutral; Raises PT & Estimates
-
Piper Jaffray Reiterates an 'Overweight' on NetLogic Microsystems (NETL); Raises PT & Estimates After Robust Qtr
-
Sinovac Biotech (SVA) Closes 1.5M Common Offering; Sees $62M Net Proceeds
-
Cisco (CSCO) Looks To Make The Right Connection In Q2
-
Notable Analyst Rating Changes 02/02: AA, Q, AXP, FCX, ACHN Upgraded; JEC, VCLK, AVAV Downgraded
-
Piper Jaffray Reiterates an 'Overweight' on Oracle (ORCL); Remains a Top Pick
-
Piper Jaffray Upgrades Qwest Communications (Q) to Overweight; Attractive Valuation
-
Piper Jaffray Upgrades Rudolph Technologies (RTEC) to Overweight; Restructures as Demand Picks Up
-
Wall Street's Thoughts On Amazon.com (AMZN) Losing E-Book Price Dispute
-
Daqo New Energy (DQ) Lowers IPO Price from $12.50-$14.50 to $10-$11
-
Piper Jaffray Downgrades Boston Scientific (BSX) Following Litigation Settlement with J&J
-
Sinovac (SVA) Prices 11.5M Shares at $5.75/Share for Net Proceeds of $62M
-
Piper Jaffray Initiates Coverage on Allied Healthcare International (AHCI) with an Overweight; Leading UK Homecare Provider
-
Piper Jaffray Reiterates an 'Overweight' on 3SBio Inc. (SSRX)
-
Wall Street's Thoughts On Amazon.com's (AMZN) Strong Q4
-
Notable Analyst Rating Changes 1/29: WMT, BCR, MAN, URBN, ARBA Upgraded; FII, BHLB, KSP Downgraded
-
Piper Jaffray Upgrades C.R. Bard (BCR) to Neutral; Valuation Call
-
Piper Jaffray Upgrades Avid Technology (AVID) to Neutral; Expect Improvement in Broadcast Ad Spend
-
Amazon.com (AMZN) Delivers Strong Q4 Results, Investors Hit the Buy Button (Update)
-
Preview of Amazon's (AMZN) Q4 Earnings, Due Out Tonight: Will the Retailer Be Able to Issue Another Amazin' Quarter?
-
Wall Street's Thoughts On Apple's (AAPL) iPad
-
Daily State of the Markets 1/28: Uncertainty Waning?
-
Sinovac Biotech (SVA) Prices 10M Common Offering at $5.75/Share
-
Goldman Sachs Removed Piper Jaffray (PJC) from Conviction Buy List
-
Piper Jaffray Upgrades STMicroelectronics (STM) to Neutral; Prefers Infineon
-
Piper Jaffray Reiterates an 'Overweight' on Deckers Outdoor (DECK); Raises PT & Estimates
-
Analyst Thoughts On Yahoo! (YHOO) After Q4 Results
-
Piper Jaffray (PJC) Posts Q4 EPS of $0.63, Tops by 10c
-
Trading Radar for 01/27: ConocoPhillips (COP), Boeing (BA), Abbott (ABT), General Dynamics (GD), E*TRADE (ETFC) Report
-
Analyst Thoughts On Apple (AAPL) After Strong Q1 Results
-
Piper Jaffray Reiterates an 'Overweight' on Atheros (ATHR); Well Positioned For Growth in 2010 - Raises Estimates & PT
-
Piper Jaffray Reiterates an 'Overweight' & Raises PT on Abercrombie & Fitch (ANF) After Visit to Flagship Store in Tokyo
-
Piper Jaffray Maintains an 'Overweight' on Apple (AAPL); Raises PT Slightly
-
Acorda's (ACOR) MS Drug Gets Nod From the FDA
-
Convio, Inc. (CNVO) Files $57.5M IPO
-
Piper Jaffray Downgrades Acorda Therapeutics (ACOR) to Neutral; Ampyra Approved; Label Clean; Moving to Neutral With Sales
-
Piper Jaffray Pounding the Table on Intel (INTC); Reiterate Overweight
-
Analyst Thoughts On Google (GOOG) After Solid Q4 Results and Subsequent Sell-Off
-
Piper Jaffray Downgrades Becton, Dickinson (BDX) to Neutral; View Pullbacks into Upper-$60's as Attractive Entry Point
-
Piper Jaffray Upgrades Genomic Health (GHDX) to Overweight; Attractive Valuation
-
Piper Jaffray Reiterates an 'Overweight' on Palm, Inc. (PALM); Anticipate Stronger Execution for Verizon Products Launch
